DIURNAL GROUP
Diurnal is an innovative pharmaceutical company that creates high-value therapeutics using advanced proprietary formulations and novel physiological treatment regimes of approved drugs for use in the endocrine (hormone) area. Founded in 2004, Diurnal is headquartered in Cardiff, United Kingdom, and is a specialty pharma company developing hormone therapeutics for the global market for the life-long treatment of chronic endocrine conditions, including congenital adrenal hyperplasia, adrenal insufficiency, and hypogonadism. Its expertise and innovative research activities focus on circadian-based endocrinology to yield novel product candidates in the rare and chronic endocrine disease arena.
DIURNAL GROUP
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2004-01-01
Address:
Cardiff, Cardiff, United Kingdom
Country:
United Kingdom
Website Url:
http://www.diurnal.co.uk
Total Employee:
11+
Status:
Active
Contact:
+441142755569
Email Addresses:
[email protected]
Total Funding:
56.6 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Universal Analytics Domain Not Resolving
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Hookipa Pharma
Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.
Current Employees Featured
Founder
Stock Details
Investors List
IP Group
IP Group investment in Venture Round - Diurnal Group
Fusion IP
Fusion IP investment in Venture Round - Diurnal Group
Fusion IP
Fusion IP investment in Debt Financing - Diurnal Group
Development Bank of Wales
Development Bank of Wales investment in Grant - Diurnal Group
Fusion IP
Fusion IP investment in Grant - Diurnal Group
Viking Fund
Viking Fund investment in Grant - Diurnal Group
Official Site Inspections
http://www.diurnal.co.uk Semrush global rank: 1.06 M Semrush visits lastest month: 31.38 K
- Host name: 52.14.198.104.bc.googleusercontent.com
- IP address: 104.198.14.52
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Diurnal Group"
Home | Diurnal | Dedicated to developing hormone therapeutics
Diurnal Limited (Company Number: 05237326) is registered in England & Wales. Registered office: Cardiff Medicentre, Heath Park, Cardiff CF14 4UJ, UK.See details»
History | Investor or Media Relations | Diurnal | Dedicated to ...
Diurnal is a European, UK-headquartered specialty pharmaceutical company dedicated to developing lifelong treatments for rare and chronic endocrine conditions. Global site; ... • …See details»
Overview | Investor or Media Relations | Diurnal | Dedicated to ...
Diurnal is a European, UK-headquartered specialty pharmaceutical company dedicated to developing lifelong treatments for rare and chronic endocrine conditions. Global site; ... Report …See details»
Company Information | Investor or Media Relations - Diurnal
Diurnal is a European, UK-headquartered specialty pharmaceutical company dedicated to developing lifelong treatments for rare and chronic endocrine conditions. ... Diurnal Group …See details»
Diurnal Group - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number +441142755569 Diurnal is an innovative pharmaceutical company that creates high-value therapeutics using advanced proprietary …See details»
Diurnal - The Org
Diurnal is a UK-based specialty pharmaceutical company dedicated to developing high-quality hormone therapeutics to aid lifelong treatment for rare and chronic endocrine conditions, …See details»
Company Profile | UK Residents | Non-HCP - Diurnal
Effective 1 November 2022, Diurnal Limited has been acquired by Neurocrine Biosciences, Inc.. Founded in 2004, DIURNAL ®, a NEUROCRINE BIOSCIENCES ® Company, is a European, …See details»
Diurnal Limited | European Clinical Trials Information Network
Diurnal Limited is a UK-based specialty pharmaceutical company that focuses on developing innovative hormone therapeutics for patients suffering from rare and chronic endocrine …See details»
Overview | UK Residents | HCP | Diurnal | Dedicated to developing ...
Diurnal Disclosure - Report 2022 Diurnal Patient Organisation Disclosure - 2022 Diurnal methodology 2022 . Diurnal methodology 2021 Diurnal Disclosure ... You are leaving . …See details»
Diurnal Group plc - AnnualReports.com
Diurnal Group plc operates as a specialty pharma company worldwide. The company develops hormone therapeutics for the treatment of chronic endocrine conditions, including congenital …See details»
Home | Investor or Media Relations | Diurnal | Dedicated to …
Welcome to Diurnal Dedicated to bringing products to the global endocrine market. Founded in 2004, DIURNAL ®, a NEUROCRINE BIOSCIENCES ® Company, is a European, UK …See details»
Diurnal Company Profile - Office Locations, Competitors ... - Craft
Nov 1, 2022 Diurnal has 5 employees at their 1 location and £4.68 m in annual revenue in FY 2022. See insights on Diurnal including office locations, competitors, revenue, financials, …See details»
Diurnal CEO and Key Executive Team | Craft.co
Diurnal's Interim Chairman, Board Representative of IP Group Plc is Sam Williams. Other executives include Anders Harfstrand, Chairman; Richard Bungay, Interim Chief Executive …See details»
Diurnal - VentureRadar
" Diurnal is an innovative pharmaceutical, venture capital backed company that creates high-value hormone therapeutics using proprietary formulations and novel physiological treatment …See details»
Diurnal - Overview, News & Similar companies | ZoomInfo.com
Aug 30, 2022 View Diurnal (www.diurnal.co.uk) location in South Glamorgan, United Kingdom , revenue, industry and description. Find related and similar companies as well as employees …See details»
Executive Team | UK Residents | Non-HCP - Diurnal
About Us. Founded in 2004, DIURNAL ®, a NEUROCRINE BIOSCIENCES ® Company, is a European, UK-headquartered specialty pharmaceutical company dedicated to developing …See details»
Executive Team | Investor or Media Relations - diurnal.co.uk
Diurnal is a European, UK-headquartered specialty pharmaceutical company dedicated to developing lifelong treatments for rare and chronic endocrine conditions. ... Diurnal Limited …See details»
BUSINESS AND TRADING UPDATE | Investor or Media Relations
Date of Preparation: January 2021 Code: CORP-GB-0093 www.diurnal.co.uk . View pdf document: Business and trading update. Diurnal Limited (Company Number: 05237326) is …See details»
Why Join Us? | Investor or Media Relations | Diurnal | Dedicated to ...
Diurnal Limited (Company Number: 05237326) is registered in England & Wales. Registered office: Cardiff Medicentre, Heath Park, Cardiff CF14 4UJ, UK. ©See details»
Diurnal announces Chief Financial Officer appointment
Cardiff, UK – Diurnal Limited, a specialty pharmaceutical company committed to the development and commercialization of orphan drugs targeting chronic endocrine diseases, today …See details»